Administrative Core
行政核心
基本信息
- 批准号:10707537
- 负责人:
- 金额:$ 30.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAdvocateAreaBasic Cancer ResearchBasic ScienceBioinformaticsBiometryCancer BiologyCancer CenterCollaborationsCommunicationCommunitiesDataData Coordinating CenterDedicationsDevelopmentEducationEnvironmentFacultyFosteringFunding AgencyFutureGoalsGrantHuman ResourcesImmuneInformation DisseminationInfrastructureInstitutionInterventionJointsLaboratoriesLeadLeadershipLinkMalignant NeoplasmsMalignant neoplasm of pancreasMedical centerMetabolicMetabolismMonitorNational Cancer InstituteNebraskaOccupational activity of managing financesOrganoidsPilot ProjectsPostdoctoral FellowProgress ReportsRecordsResearchResearch PersonnelResearch Project GrantsResistanceResourcesScheduleScienceScientistSignal TransductionStromal NeoplasmStudentsTalentsTechnical ExpertiseTestingTissuesTranslational ResearchTravelUniversitiesWorkanticancer researchcancer therapydata integrationgraduate studentinnovationinterestmeetingsmembermouse modelnext generationnovelnovel therapeutic interventionoperationpreventprogramsprospectiveresistance mechanismtherapy resistanttranslational cancer researchtranslational pipelinetranslational research programtumortumor metabolismweb portal
项目摘要
ADMINISTRATIVE CORE
Abstract
The administrative core will lead, manage, and support all activities of the Acquired Resistance to Therapy
Network (ARTNet) Center for Pancreatic Cancer (ACPC). It will represent ACPC at the trans-ARTNet network
activities, and in interactions with NCI. The ARTNet administrative core will be responsible for managing the
activities of the synergistic research ACPC projects with scientific and technical expertise and resources in the
areas of therapy resistance, signaling, metabolism, pancreatic cancer biology, organoid and mouse models,
immune and non-immune stroma, and PDAC tissues for studying the acquired therapy resistance in cancer. The
core leadership will provide expertise spanning the basic to translational spectrum, consistent with the
overarching theme of ACPC, with track records of building and guiding large scientific teams to successfully
advance fields in transformative ways. We will utilize strategic management with innovative approaches,
including an educational component to bring new talent into the field, engage diverse teams to facilitate new
ideas, leverage national talent pertinent to the proposed goals, engage university leadership in building support
for cutting-edge science, and utilize dedicated university expertise to facilitate engagement with basic and
translational research programs to grow ARTNet centric interests. The administrative core will provide support
for personnel involved in the administration, coordination, communication, biostatistics, and bioinformatics to
support the ARTNet activities within the center and campus, other ARTNet centers, ARTNet Coordinating Data
and Management Center (CDMC) and National Cancer Institutes (NCI). The administrative core will also provide
scientific oversight, result dissemination, budgetary oversight, and clerical functions associated with the overall
research program in this ACPC application. The core will implement center-wide activities which include,
developing new collaborations on the ACPC projects, organize annual retreat, support acquired cancer therapy
resistance seminar speakers within various academic units, advocate for the next generation of scientists
(graduate students, postdoctoral researchers, and junior faculty) in the ACPC member laboratories. Finally, the
administrative core will represent ACPC on the ARTNet steering committee.
行政核心
抽象的
行政核心将领导、管理和支持获得性治疗抵抗的所有活动
胰腺癌网络 (ARTNet) 中心 (ACPC)。它将在跨 ARTNet 网络中代表 ACPC
活动以及与 NCI 的互动。 ARTNet 管理核心将负责管理
ACPC 项目与科学技术专业知识和资源的协同研究活动
治疗耐药性、信号传导、代谢、胰腺癌生物学、类器官和小鼠模型等领域,
免疫和非免疫基质以及 PDAC 组织,用于研究癌症的获得性治疗耐药性。这
核心领导层将提供从基础到转化领域的专业知识,与
ACPC 的总体主题,拥有建立和指导大型科学团队成功的记录
以变革性的方式推进领域。我们将以创新的方式运用战略管理,
包括教育部分,以将新人才带入该领域,让多元化的团队参与进来,以促进新的
想法,利用与拟议目标相关的国家人才,让大学领导层建立支持
尖端科学,并利用专门的大学专业知识来促进基础和
转化研究项目以培养以 ARTNet 为中心的兴趣。行政核心将提供支持
参与行政、协调、沟通、生物统计和生物信息学的人员
支持中心和校园内的 ARTNet 活动、其他 ARTNet 中心、ARTNet 协调数据
管理中心 (CDMC) 和国家癌症研究所 (NCI)。行政核心还将提供
与总体相关的科学监督、结果传播、预算监督和文书职能
此 ACPC 应用程序中的研究计划。核心将实施中心范围的活动,其中包括:
在 ACPC 项目上开展新的合作,组织年度静修会,支持获得性癌症治疗
各个学术单位的抵抗研讨会发言人,倡导下一代科学家
ACPC 成员实验室的(研究生、博士后研究人员和初级教师)。最后,
行政核心将在 ARTNet 指导委员会中代表 ACPC。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pankaj Kumar Singh其他文献
In silico guided development of imine-based inhibitors for resistance-deriving kinases
计算机引导开发基于亚胺的耐药激酶抑制剂
- DOI:
10.1080/07391102.2018.1491893 - 发表时间:
2018-11-20 - 期刊:
- 影响因子:4.4
- 作者:
Pankaj Kumar Singh;O. Silakari - 通讯作者:
O. Silakari
Experimental Analysis of Autogenous Healing in Early Stage of Concrete
混凝土早期自愈合试验分析
- DOI:
10.51976/jfsa.322002 - 发表时间:
2024-09-14 - 期刊:
- 影响因子:0
- 作者:
Ch;ra Shekher Giri;ra;Pankaj Kumar Singh - 通讯作者:
Pankaj Kumar Singh
Supramolecular Nanofibers of Curcumin for Highly Amplified Radiosensitization of Colorectal Cancers to Ionizing Radiation
姜黄素超分子纳米纤维对结直肠癌电离辐射的高放大放射增敏作用
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:19
- 作者:
Huae Xu;Tingting Wang;Chenbiao Yang;Xiaolin Li;Guan Liu;Zhimou Yang;Pankaj Kumar Singh;Sunil Krishnan;Dan Ding - 通讯作者:
Dan Ding
Bioprospecting of marine diatoms Thalassiosira, Skeletonema and Chaetoceros for lipids and other value-added products.
对海洋硅藻海链藻、骨条藻和角毛藻进行生物勘探,以获取脂质和其他增值产品。
- DOI:
10.1016/j.biortech.2020.124073 - 发表时间:
2020-09-03 - 期刊:
- 影响因子:11.4
- 作者:
Raya Bhattacharjya;Thomas Kiran Marella;A. Tiwari;A. Saxena;Pankaj Kumar Singh;Bharti Mishra - 通讯作者:
Bharti Mishra
Sustainable strategy for enhancing growth of marine diatom and lipid production using RO and AC spent water
利用 RO 和 AC 废水促进海洋硅藻生长和脂质生产的可持续战略
- DOI:
10.1007/s43393-024-00242-2 - 发表时间:
2024-03-17 - 期刊:
- 影响因子:0
- 作者:
Raya Bhattacharjya;Pankaj Kumar Singh;Rashi Tyagi;Subha Rastogi;Archana Tiwari - 通讯作者:
Archana Tiwari
Pankaj Kumar Singh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pankaj Kumar Singh', 18)}}的其他基金
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
FOLFIRINOX 在胰腺癌中获得性耐药的代谢调节
- 批准号:
10518247 - 财政年份:2022
- 资助金额:
$ 30.72万 - 项目类别:
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
胰腺癌转移和进展中的线粒体钙信号传导
- 批准号:
10565949 - 财政年份:2022
- 资助金额:
$ 30.72万 - 项目类别:
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
胰腺癌转移和进展中的线粒体钙信号传导
- 批准号:
10363987 - 财政年份:2022
- 资助金额:
$ 30.72万 - 项目类别:
Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer
ME2 介导的胰腺癌肿瘤抑制的分子基础
- 批准号:
10671029 - 财政年份:2022
- 资助金额:
$ 30.72万 - 项目类别:
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
FOLFIRINOX 在胰腺癌中获得性耐药的代谢调节
- 批准号:
10707541 - 财政年份:2022
- 资助金额:
$ 30.72万 - 项目类别:
相似海外基金
Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤
- 批准号:
10566833 - 财政年份:2023
- 资助金额:
$ 30.72万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709602 - 财政年份:2022
- 资助金额:
$ 30.72万 - 项目类别: